BioCentury
ARTICLE | Company News

ChemBridge, MethylGene small molecule deal

December 12, 2001 8:00 AM UTC

ChemBridge (San Diego, Calif.) and MethylGene (Montreal, Quebec) partnered develop small molecule inhibitors of up to 10 mutually selected enzyme targets for cancer and infectious disease. The deal wi...